313 related articles for article (PubMed ID: 19218854)
1. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.
van Zoelen MA; Yang H; Florquin S; Meijers JC; Akira S; Arnold B; Nawroth PP; Bierhaus A; Tracey KJ; van der Poll T
Shock; 2009 Mar; 31(3):280-4. PubMed ID: 19218854
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats.
Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Rodriguez Guerrero A; Kobayashi S; Ma WY; Liu SY; Zhu P; Baba H
Spine (Phila Pa 1976); 2011 Dec; 36(25):2122-9. PubMed ID: 21343866
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
4. The pro-inflammatory role of high-mobility group box 1 protein (HMGB-1) in photoreceptors and retinal explants exposed to elevated pressure.
Böhm MR; Schallenberg M; Brockhaus K; Melkonyan H; Thanos S
Lab Invest; 2016 Apr; 96(4):409-27. PubMed ID: 26779828
[TBL] [Abstract][Full Text] [Related]
5. Early release of HMGB-1 from neurons after the onset of brain ischemia.
Qiu J; Nishimura M; Wang Y; Sims JR; Qiu S; Savitz SI; Salomone S; Moskowitz MA
J Cereb Blood Flow Metab; 2008 May; 28(5):927-38. PubMed ID: 18000511
[TBL] [Abstract][Full Text] [Related]
6. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
Park JS; Svetkauskaite D; He Q; Kim JY; Strassheim D; Ishizaka A; Abraham E
J Biol Chem; 2004 Feb; 279(9):7370-7. PubMed ID: 14660645
[TBL] [Abstract][Full Text] [Related]
7. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
8. High-mobility group box-1 increases epithelial sodium channel activity and inflammation via the receptor for advanced glycation end products.
Grant GJ; Liou TG; Paine R; Helms MN
Am J Physiol Cell Physiol; 2020 Mar; 318(3):C570-C580. PubMed ID: 31913693
[TBL] [Abstract][Full Text] [Related]
9. Association analysis of high-mobility group box-1 protein 1 (HMGB1)/toll-like receptor (TLR) 4 with nasal interleukins in allergic rhinitis patients.
Zhu X; Cong J; Yang B; Sun Y
Cytokine; 2020 Feb; 126():154880. PubMed ID: 31739216
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q
J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
Yu M; Wang H; Ding A; Golenbock DT; Latz E; Czura CJ; Fenton MJ; Tracey KJ; Yang H
Shock; 2006 Aug; 26(2):174-9. PubMed ID: 16878026
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
[TBL] [Abstract][Full Text] [Related]
13. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.
Hreggvidsdóttir HS; Lundberg AM; Aveberger AC; Klevenvall L; Andersson U; Harris HE
Mol Med; 2012 Mar; 18(1):224-30. PubMed ID: 22076468
[TBL] [Abstract][Full Text] [Related]
14. High mobility group box 1 protein interacts with multiple Toll-like receptors.
Park JS; Gamboni-Robertson F; He Q; Svetkauskaite D; Kim JY; Strassheim D; Sohn JW; Yamada S; Maruyama I; Banerjee A; Ishizaka A; Abraham E
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C917-24. PubMed ID: 16267105
[TBL] [Abstract][Full Text] [Related]
15. HMGB-1 induces c-kit+ cell microvascular rolling and adhesion via both toll-like receptor-2 and toll-like receptor-4 of endothelial cells.
Furlani D; Donndorf P; Westien I; Ugurlucan M; Pittermann E; Wang W; Li W; Vollmar B; Steinhoff G; Kaminski A; Ma N
J Cell Mol Med; 2012 May; 16(5):1094-105. PubMed ID: 21762373
[TBL] [Abstract][Full Text] [Related]
16. Role of scavenger receptors as damage-associated molecular pattern receptors in Toll-like receptor activation.
Komai K; Shichita T; Ito M; Kanamori M; Chikuma S; Yoshimura A
Int Immunol; 2017 Feb; 29(2):59-70. PubMed ID: 28338748
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia.
Achouiti A; van der Meer AJ; Florquin S; Yang H; Tracey KJ; van 't Veer C; de Vos AF; van der Poll T
Crit Care; 2013 Dec; 17(6):R296. PubMed ID: 24342460
[TBL] [Abstract][Full Text] [Related]
18. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
Qiu J; Xu J; Zheng Y; Wei Y; Zhu X; Lo EH; Moskowitz MA; Sims JR
Stroke; 2010 Sep; 41(9):2077-82. PubMed ID: 20671243
[TBL] [Abstract][Full Text] [Related]
19. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
